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ABSTRACT: Accelerated proton beams have become increasingly common for treating cancer. 
The need for cost and size reduction of particle accelerating machines has led to the pioneering 
investigation of optical ion acceleration techniques based on laser-plasma interactions as a 
possible alternative. Laser-matter interaction can produce extremely pulsed particle bursts of 
ultra-high dose rates (≥ 109 Gy/s), largely exceeding those currently used in conventional proton 
therapy. Since biological effects of ionizing radiation are strongly affected by the spatio-
temporal distribution of DNA-damaging events, the unprecedented physical features of such 
beams may modify cellular and tissue radiosensitivity to unexplored extents. Hence, clinical 
application of laser-generated particles needs assessment of their radiobiological effectiveness. 
To date, the majority of studies have either used rodent cell lines or have focussed on cancer cell 
killing being local tumour control the main objective of any radiotherapy strategy. However, 
very little data exist on sub-lethal cellular effects of relevance to normal tissue integrity such as 
premature cellular senescence. Here, we briefly discuss ultra-high dose rate radiobiology and 
present preliminary data obtained in normal human cells following irradiation by laser-
accelerated protons at the LULI PICO2000 facility at Laser Lab Europe, France. 
KEYWORDS: Laser-driven proton beams; Radiobiological effectiveness; Sub-lethal effects and 
premature cellular senescence. 
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1. The rationale for laser-driven cancer hadrontherapy 
Hadrontherapy, the clinical exploitation of accelerated charged particles for cancer treatment, 
has become an increasingly common therapeutic modality [1], because of several advantages it 
offers compared to conventional radiotherapy with megavoltage photon or electron beams. The 
use of charged particles significantly reduces the dose absorbed by normal tissues due to their 
inverse dose-depth deposition profile as described by the Bragg curve. Their superior ballistic 
properties are thus the physical pillar justifying hadrontherapy as the eligible treatment for deep-
seated tumours and/or close to organs at risk [2]. Heavier charged particles such as carbon ions 
exhibit a higher radiobiological effectiveness than protons or photons, due to their denser 
ionization event pattern through matter, whereby highly clustered DNA lesion sites arise. Such 
damage complexity is believed to confer high-LET radiations their radiobiological advantage at 
cell killing [3], hence making carbon-ion based radiotherapy best suited to treat intrinsically 
radioresistant cancers [4]. However, a wider adoption of hadrontherapy is hampered by the high 
installation and running costs of the accelerating facilities [5]. This has fuelled efforts in 
developing novel approaches to obtain a compact, flexible and cost-effective solution to 
accelerate particles for medical applications. One viable solution may be represented by laser-
based optical ion acceleration techniques [6]. Clinically amenable laser-driven beams require 
specific constraints to be met, such as beam reproducibility, homogeneity and stability. More 
importantly, the radiobiological effectiveness of these beams needs must be assessed. For they 
exhibit unprecedented spatio-temporal physical features [7]. The physical pattern of the energy 
deposition events at nanometric scale and their subsequent very early stage (10-12-10-6 s) 
radiochemical evolution determines the biological outcome, shaping the role of biochemical 
repair processes [8]. The ultra-intense (≥1019W/cm2) nature of the laser-target interaction 
foreseen to produce proton beams of energies suitable for hadrontherapy gives rise to ultra-short 
(from fs to ps) proton bursts at ultra-high dose rates (≥109Gy/s), i.e. several orders of magnitude 
larger than the ones used in the current therapeutic regimes [9]. While laser-driven particle 
beams can be thus seen as a valuable probe to investigate the core mechanisms of radiation 
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action at the sub-nanometer and femtosecond scales [10,11], it has been suggested that the 
extreme spatio-temporal nature of laser-driven particle beams may ensue unknown biological 
responses [7,12,13]. Hence, ultra-fast high-energy particle radiobiology will have to ascertain 
whether and to what extent cellular radiosensitivity is influenced by such peculiar irradiation 
regimes. Whereas local tumour control is the aim of any curative radiotherapy, late-occurring 
effects such as recurrence or metastatization represent its most feared consequence. These stem 
from cells that are sub-lethally damaged by irradiation and by the interplay between these and 
neighbouring cancer cells. In particular, very little experimental data exist on the induction of 
sub-lethal cytogenetic damage along the Bragg curve, adding to the uncertainties deriving from 
still scant clinical follow-up data on sequelae incurred by hadrontherapy patients. A fortiori, the 
dependence of sub-lethal effects on unprecedented factors, such as the exceedingly high dose 
rates and/or the pulsed nature of beams originated by laser interaction with target materials,  
needs investigation prior to actual laser-driven cancer hadrontherapy. Here we present 
preliminary work carried out at LULI PICO2000 laser facility focusing on cellular premature 
senescence in a normal human cell line.  
 
2. The radiobiology of ultra-fast high-energy particles 
Because of the increasing attention towards alternative modalities for cancer hadrontherapy, 
there has been a revival in recent years in the field of ultra-high dose rate (UHDR) radiobiology. 
In fact, an ample spectrum of dose rate values has been historically used in experimental 
radiobiology and clinical radiotherapy [14], extending from a few cGy per day to hundreds of 
Gy in a fraction of a second (Figure 1). The extremes of the spectrum have bene largely 
considered of mere academic interest as has been the case for the low end of the spectrum, i.e. 
chronic exposure regimes typical of interstitial brachytherapy, also of relevance to 











Figure 1: A sketch of the dose-rate spectrum of interest in radiobiology and radiotherapy: highlighted is 
the mechanistic basis hypothesized for biological effects due to UHDR and/or highly pulsed radiation 
regimes (adapted from [14]) 
 
Indeed, exploration of the top range of the dose.rate spectrum was long hampered by the 
technical difficulty of achieving such extreme conditions. The most complete set of data 
concerning the dose-rate effect has been accumulated in vitro for a number of biological 
systems in the range between 0.1 Gy/hr and 10 Gy/min, demonstrating the principle of repair of 
sub-lethal damage (15, 16). Oxygen concentration was seen to be critical as an increase in cell 
survival with decreasing dose rates was seen to be much reduced under hypoxic conditions [17], 
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pointing to less recoverable, intra-track lethal damage. At the opposite end of the dose-rate 
range, early studies invoked oxygen consumption by radiation concomitantly with an increased 
likelihood of recombination during free radical formation to explain a diminished biological 
effectiveness under UHDR [18].  UHDR were  attained by discharge machines or electron linear 
accelerators: by both methods, estimated instantaneous dose rates of 1011 Gy/min could be 
obtained [14]. If both the dose and instantaneous dose rate are sufficiently high, the rapid 
deposition of radiant energy depletes oxygen too quickly for diffusion to maintain an adequate 
level of oxygenation, and dose-response curves obtained are those characteristic of hypoxia, i.e. 
lacking the shoulder at low dose where cell killing is inefficient because of sub-lethal damage 
repair. The promise that these findings held for radiotherapy was based on the thought that 
UHDR would constitute a means of killing cells independent of oxygen tension since at 
sufficiently high dose rates even aerated cells would behave as if they were anoxic. This would 
represent an ideal radiation modality for radiotherapy since the protection afforded to some 
tumour cells by their hypoxia would be completely eliminated. For bacteria, a firmly established 
dose-rate effect in the UHDR region exists as first demonstrated by an anoxic-like response of 
bacteria irradiated in 1 % oxygen [19]. This biphasic type of response was confirmed by others 
[20] irradiating mammalian cells equilibrated in air (Figure 2). Nias et al. showed instead lack 
of anoxic-like response and no differences in radiosensitivity after irradiation with highly pulsed 
electrons of oxyc cells [21].  Further studied failed to clarify the influence of UHDR and pulsed 
irradiation modality on cellular response. Schulz et al. [22] found a pulsed 30-MeV electron 
beam at 0.5 - 5 108 Gy/s to be less effective at cell killing compared to 250 kV X-rays, but they 
could not relate their results to oxygen consumption. Purdie et al. [23] found opposite results 
using similar experimental conditions. These conflicting results, together with the consideration 
that total doses required to use up local oxygen are far too high, and the instantaneous dose-rates 
enormous, led to a decline of interest in this development for the clinic. At least, prior to the 














Figure 2: The typical “hockey-stick” type shape of the clonogenic survival dose response curves from  
γ-rays at conventional dose rate (1 Gy min-1) or to a 7-ns pulse of electrons (from [19]). 
 
Several groups have started preliminary work using laser-driven ion sources for cell irradiation 
experiments. The main aim of these investigations so far has been to establish a procedure for 
cell handling, irradiation and dosimetry compatible with a laser-plasma interaction environment. 
Activities in this area have been carried out in Germany [24-26] and Japan [27], where, using 
 
 
– 4 – 
Ti:Sa lasers, lethal effects on cells have been investigated by accumulating dose on cells over 
several laser shots, with an effective dose rate of Gy/s or Gy/min. An UHDR radiobiology 
program was initiated on the TARANIS and GEMINI laser systems in the UK, employing a 
single exposure approach (single-shot irradiations), which is believed to be more relevant to 
isolate effects associated to short burst deposition, as the dose required to induce biological 
effects is deposited in a single, ultrashort burst [28, 29]. Neither approach did find significant 
radiobiological differences between laser-driven electrons or protons and conventionally 
accelerated beams or reference photon radiations. In fact, the majority of in vitro studies making 
use of different sources confirm that in the therapeutically relevant dose range of a few Gy, even 
if applied in a single pulse of only few nanoseconds duration, non-linear radiobiological effects 
due to simultaneous multiple damages in cells and, thus, below any timescale of repair 
mechanisms, are unlikely to arise [30-35]. Only two relevant exceptions exist: Achayra et al. 
[36], who reported a decrease in genetic damage measured as micronucleus formation after a 
single pulse of electrons but not after multiple pulses (106 to 108 Gy/s), hypothesising more 
efficient radical recombination; Schmid et al. [37], who found a slight decrease in effectiveness 
at causing (some types of) chromosome aberrations after nanopulsed protons (conventionally 
accelerated). Of fundamental importance to gain insights into laser-driven particle biological 
effectiveness is, of course, in vivo work. From these studies, mainly limited to tumour growth 
delay as endpoint of clinical relevance and still too scarce for firm conclusions to be drawn, no 
enhancing effects have emerged  for both protons and electrons [38-40]. 
 
3. Sub-lethal cellular damage and particle therapy 
Despite allowing considerable normal tissue sparing, a main health concern of hadrontherapy 
remains the onset of secondary cancers [41]. The tumorigenic potential of ionizing radiation has 
been long known as well as its dependence on dose, dose rate and radiation quality [42]. 
However, non-cancer late effects may also undermine overall treatment success. Recent 
evidence suggests a significantly higher risk of developing cardiovascular disease in patients 
cured for breast cancer, in which heart and/or blood vessel are deemed to receive some dose, 
which is in line with the results from the epidemiological studies on the Japanese atomic bombs 
survivors [43]. Stress-induced premature senescence (SIPS), a process whereby sub-lethally 
damaged cells enter a permanent state of quiescence, has attracted growing interest for its 
possible long-term health consequences [44, 45]. This is opposed to the well-known 
phenomenon of in vitro replicative senescence, which is the physiological exhaustion of a cell’s 
ability to proliferate [46], mechanistically linked with the progressive shortening of end-
chromosome sequences (telomeres) [47], and universally recognised as a natural barrier to 
tumorigenesis in vivo [48,49]. In particular, ionizing radiation is capable of inducing SIPS and, 
more interestingly, charged particles have proven particularly effective at eliciting a senescence 
response at very low dose and dose rates [50, 51]. Ectopic accumulation in vivo of senescing 
cells may adversely affect normal tissue/organ integrity and/or function resulting in genomic 
instability and increased risk of cancer [52-54]. In hadrontherapy patients, the role of SIPS is 
still undetermined [55, 56]. In addition, because senescing cells remain metabolically active 
[46],  a Senescence -Associated Secretory Phenotype (SAPS) has been identified whose effect 
on neighboring primary cancer cells is controversial as secretion of factors released by cells 
undergoing SIPS has been associated with either the inhibition or the promotion of 
proliferation/invasiveness [57-59]. Therefore, sub-lethal effects clearly play a role as important 
as tumor local control in determining the successful outcome of cancer radiation treatment. To 
 
 
– 5 – 
date, there is no knowledge on the influence that very high dose rates or pulsed time-structure in 
dose delivery may have on such effects. 
4. Radiobiological studies with laser-accelerated protons at the PICO2000 facility              
4.1 Experimental setup   
 
Protons were generated from the interaction of laser bursts focused on 25 and 50 µm Au foil 
targets. Laser energy was, on average, of (100±10) J with a pulse duration of 1.3 ps ( mean laser 
intensity of approximately 5×1019 W/cm2).  A dipole deflected the plasma-accelerated protons 
as to angularly disperse them according to their energy.  Parasitic X-ray radiation was 
suppressed by appropriate lead shielding in the chamber, while X-rays were spatially separated 
from the deflected protons. A purposely designed cell dish was used for biological sample 
irradiation, with cells growing on its 3-µm mylar basis. To optimize sample irradiation, we 
simultaneously exposed three cell dots in one shot (on the same dish), each at a specific energy 








Figure 3: Proton beam transport and delivery system (left); Scheme of the cell dish and cell 
positioning(right) 
 
After exposure, cells from each dot were treated independently. Radiochromic films (RCF), 
image plates (IP) and nuclear track detectors (CR39) were used for dosiemtry. Prior to cell 
irradiation, low-sensitivity HD-V2 RCF were positioned inside the target chamber at about 5 cm 
from the proton source, in order to study the beam input properties, in terms of energy and 
angular distribution.  High-sensitivity EBT3 RCFs were placed outside the target chamber, just 
behind the biological sample, in an ad hoc frame, as to provide a shot-to-shot characterization of 
the dose. IP were employed to directly assess the energy distribution and its spatial uniformity 
at the sample position. CR39, instead, were used to estimate the particles fluence and 
homogeneity, and to cross-calibrate the IP. The energy differences within the dot-containing 
dish region varied in a range of 6 to 14 MeV, with a 10% dispersion approximately, 
corresponding to a biologically irrelevant LET variation (5±2 keV/um). Hence, it was possible 
for the radiobiological data to be grouped by dose. Human Umbilical Vein Endothelial 
(HUVEC) cells were aliquoted as three dots of 20 µl each of cell suspension, corresponding 
approximately to 15.000 cells, and seeded onto the cell dish 24 h before exposure. The three 
mean doses estimated at the cell positions were (0.6±0.2) Gy, (1.8±0.6) Gy and (4.5±0.8) Gy. 
The onset of cellular senescence in irradiated cells was assessed by affinity for β-galactosidase 
expression, both at early time post-irradiation (2 days) and at later times. Clonogenic survival 
was also studied as it represents the standard measure for cell radiosensitivity. Results were 
compared against data from experiments with conventionally accelerated protons (mid-SOBP, 
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4.2 Results  
 
Surviving fractions (SF) were fitted according to the linear-quadratic model SF=exp-(αD-βD2). 
No statistically significant difference between cellular survival to laser-driven and 
conventionally accelerated proton beams was observed (Figure 4). An RBE of 1.1 was found 
between conventional proton irradiation and X-rays, in line with the universally accepted value 
in protontherapy planning treatments. Figure 5 illustrates the time course of radiation-induced 
cellular senescence. All irradiation conditions resulted in an increase in the fraction of senescing 
cells. In particular, proton irradiations were generally more effective than X-rays. As for laser-
driven and conventionally accelerated protons, the former appeared less effective at the lowest 
dose, of relevance for healthy tissues in a radiotherapy scenario. Conversely, at the intermediate 
dose used in our experiments (1.5 Gy, 1.8±0.5 Gy for laser-driven protons), i.e. a value close to 
the fractionated therapeutic dose of 2 Gy administered to the tumor volume, occurrence of 
senescence induced by laser-driven protons was at all times greater than that by conventionally 
accelerated protons . At the highest dose used (4 Gy, 4.5±0.8 Gy for laser-driven protons) there 











Figure 4: HUVEC clonogenic survival curves following laser-driven beam (red symbols) and 
conventionally accelerated beam (blue symbols). Results of X-ray irradiation (black symbols) are shown 















Figure 5: Time course of HUVEC senescence induction grouped by doses. Black triangles highlight the 
statistically significant differences between laser-driven and conventionally accelerated protons (p<0.05). 
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4.3 Conclusions 
To our knowledge, the data here presented are the first ones obtained on radiation-induced 
premature senescence, an important sub-lethal effect of potential clinical relevance, in normal 
cells exposed to laser-accelerated particles.  Laser-driven proton beams were found to yield a 
higher percentage of senescing cells at quasi-therapeutic doses while causing a lower percentage 
of cells to enter prematurely senescence at doses typical of healthy tissues.  The potential 
clinical implications are intriguing since a greater effect at the tumor level (in vivo senescing 
endothelial cells may translate in disruption of the blood vessels feeding the tumor) seems to be 
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